Clinical Trial Update: Radiation Therapy With Capecitabine in Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of radiation therapy with capecitabine for rectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Xeloda (capecitabine)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Rectal Cancer | Phase 2 | Status: TERMINATED